JANUET 50/850 MG TABLETS

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

METFORMIN HYDROCHLORIDE 850 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG

Mevcut itibaren:

MERCK SHARP & DOHME ISRAEL LTD

ATC kodu:

A10BA02

Farmasötik formu:

TABLETS

Uygulama yolu:

PER OS

Tarafından üretildi:

MERCK SHARP & DOHME CORP., USA

Terapötik grubu:

METFORMIN

Terapötik endikasyonlar:

Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.

Yetkilendirme tarihi:

2009-01-01